ROIV News

Key Factors

Recent Updates

Catalyst

Recent Bullish Engulfing and Marubozu White signals alongside a dominant count of bullish technical indicators point to rebound momentum for ROIV.

Risk

Large and extra-large institutional investors are exiting the stock, creating net outflow pressure despite small-cap buying.

Generated at22:0003/26/2026by

Aime

Newswire

10:32

Roivant Sciences: Bollinger Bands expand downward, KDJ death cross signals potential decline.

14:34

Roivant Sciences' 15min chart shows Bollinger Bands narrowing, KDJ Death Cross.

14:21

Roivant Sciences' 15-min chart sees MACD Death Cross, Bollinger Bands Narrowing

12:19

Roivant Sciences's 15min chart shows MACD Death Cross and Bollinger Bands Narrowing.

10:17

Roivant Sciences's 15min chart shows KDJ Death Cross, Bearish Marubozu pattern.

About ROIV

Charts

SectorBiological Technology

Established Date06/07/2020

Listing Date08/12/2020

ExchangeNASDAQ Stock Exchange

Full-time Employees750

Fiscal Year Ends31/03

Websiteroivant.com;investor.roivant.com

Security TypeCommon stock

Office address7th Floor, 50 Broadway, London SW1H 0DB, United Kingdom

Business

Introduction

Roivant Sciences Ltd., a company registered in Bermuda, was established on July 6, 2020. Roivant's mission is to improve healthcare delivery to patients by treating every inefficiency as an opportunity. Roivant utilizes the Roivant platform to launch "Vants" — flexible and focused biopharmaceutical and health technology companies to develop transformative drugs faster by building technology and cultivating talent in a creative way.